This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of TherapeuticsMD Inc. shed 3.3% to $0.74 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.7% to 17,504.12 and Dow Jones Industrial Average falling 0.6% to 41,581.31.
TherapeuticsMD Inc. closed 69.5% short of its 52-week high of $2.44, which the company reached on January 3rd.
The stock underperformed when compared to some of its competitors, as AbbVie Inc. fell 0.3% to $213.85.
Trading volume totaled 20,289, compared to the 50-day average of 674,285.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 18, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。